Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TANDEM DIABETES CARE INCTNDM · Entity 4682 | Chair Emeritus | May 20, 2026 | May 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TANDEM DIABETES CARE INC
Report date May 20, 2026 · Filed May 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,146 |
Reported balance
After 2026-05-21 transaction · row 1
1 source rowRow 1 · 2026-05-21 · Exercise / conversion · Acquired 8,759 · Balance 28,146 |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 10,220 |
Reported balance
After 2026-05-20 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-05-20 · Grant · Acquired 10,220 · Balance 10,220 F2: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F3: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan. |
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-05-21 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-05-21 · Exercise / conversion · Disposed 8,759 · Balance 0 F2: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan). F4: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 22,757 |
Reported balance
Holding disclosure · report date 2026-05-20 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 22,757 F1: The securities are held by the Allen Family Trust dated October 12, 1981. |
Filing footnotes · ownership attribution and instrument terms
F1: The securities are held by the Allen Family Trust dated October 12, 1981.
F2: Each restricted stock units (RSU) represents a contingent right to receive either one share of the Issuers common stock or cash in lieu thereof, at the Issuers discretion, in accordance with the terms of the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
F3: Such RSUs were granted to the Reporting Person on May 20, 2026, and will vest on the one-year anniversary thereof, subject to the terms of the 2023 Plan.
F4: On May 21, 2025, the Reporting Person was granted 8,759 RSUs, all of which vested and converted into shares of the Issuers common stock on the one-year anniversary thereof in accordance with the 2023 Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 07, 2020 Filed May 8, 2020 20:25 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 500 | $89.00 | $44,500.00 |
DisclosureSEC source: 0001438133-20-000045 · wf-form4_158896949182434.xml · nonDerivative · entry 3 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 1,000 F1 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 04, 2020. F4 · ownership.nature: The securities are held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Jake Allen Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon. Read SEC document |
| May 07, 2020 Filed May 8, 2020 20:25 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 500 | $89.00 | $44,500.00 |
DisclosureSEC source: 0001438133-20-000045 · wf-form4_158896949182434.xml · nonDerivative · entry 2 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote(s) Disclosed balance after: 1,000 F1 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 04, 2020. F3 · ownership.nature: The securities are held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon. Read SEC document |
| May 07, 2020 Filed May 8, 2020 20:25 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 2,500 | $89.00 | $222,500.00 |
DisclosureSEC source: 0001438133-20-000045 · wf-form4_158896949182434.xml · nonDerivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes) Disclosed balance after: 7,526 F1 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 04, 2020. F2 · ownership.nature: The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 23:03 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionWarrant · Derivative | 2,778 | $73.73 Strike: $73.73 | $204,821.94 |
DisclosureSEC source: 0001438133-20-000019 · wf-form4_158293099576654.xml · derivative · entry 8 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 0 Underlying: Common Stock · 2,778 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.expiration_date: The expiration dates for this warrant are August 31, 2021 (1,356 shares), May 25, 2022 (596 shares) and July 17, 2022 (826 shares). F3 · ownership.nature: The securities are held by the Allen Family Trust dated October 12, 1981. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 23:03 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionWarrant · Derivative | 406 | $73.73 Strike: $73.73 | $29,934.38 |
DisclosureSEC source: 0001438133-20-000019 · wf-form4_158293099576654.xml · derivative · entry 7 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 406 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.expiration_date: The expiration dates for this warrant are August 31, 2021 (271 shares) and July 3, 2022 (135 shares). F2 · ownership.nature: The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 23:03 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 2,599 | $78.82 | $204,853.18 |
DisclosureSEC source: 0001438133-20-000019 · wf-form4_158293099576654.xml · nonDerivative · entry 4 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 37,179 F1 · kind: The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.73. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer. F3 · ownership.nature: The securities are held by the Allen Family Trust dated October 12, 1981. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 23:03 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 2,778 | $73.73 | $204,821.94 |
DisclosureSEC source: 0001438133-20-000019 · wf-form4_158293099576654.xml · nonDerivative · entry 3 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 39,778 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.73. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer. F3 · ownership.nature: The securities are held by the Allen Family Trust dated October 12, 1981. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 23:03 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 380 | $78.82 | $29,951.60 |
DisclosureSEC source: 0001438133-20-000019 · wf-form4_158293099576654.xml · nonDerivative · entry 2 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes) Disclosed balance after: 10,026 F1 · kind: The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.73. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer. F2 · ownership.nature: The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 23:03 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 406 | $73.73 | $29,934.38 |
DisclosureSEC source: 0001438133-20-000019 · wf-form4_158293099576654.xml · nonDerivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes) Disclosed balance after: 10,406 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.73. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer. F2 · ownership.nature: The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:28 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantCommon Stock · Derivative | 1,700 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001438133-20-000009 · wf-form4_158051331288537.xml · derivative · entry 16 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Stock Option · 1,700 shares Expires not disclosed F13 · derivative.exercise_date: The option vested in twelve (12) equal monthly installments after one year from grant. F12 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:28 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock · Derivative | 5,300 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001438133-20-000009 · wf-form4_158051331288537.xml · derivative · entry 15 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Stock Option · 5,300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: The option vested in twelve (12) equal monthly installments after one year from grant. F12 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:28 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock · Derivative | 1,700 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0001438133-20-000009 · wf-form4_158051331288537.xml · derivative · entry 14 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Stock Option · 1,700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: The option vested in twelve (12) equal monthly installments after one year from grant. F12 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:28 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock · Derivative | 1,671 | $0.00 Strike: $11.06 | $0.00 |
DisclosureSEC source: 0001438133-20-000009 · wf-form4_158051331288537.xml · derivative · entry 13 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Stock Option · 1,671 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: The option shall vest in equal monthly installments for a period of twenty-four(24) months. F12 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:28 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,700 | $76.15 | $129,455.00 |
DisclosureSEC source: 0001438133-20-000009 · wf-form4_158051331288537.xml · nonDerivative · entry 8 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person August 22, 2019. F6 · price: The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $76.06 to $76.54. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:28 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,700 | $2.54 | $4,318.00 |
DisclosureSEC source: 0001438133-20-000009 · wf-form4_158051331288537.xml · nonDerivative · entry 7 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:28 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 5,300 | $75.95 | $402,535.00 |
DisclosureSEC source: 0001438133-20-000009 · wf-form4_158051331288537.xml · nonDerivative · entry 6 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person August 22, 2019. F5 · price: The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $75.87 to $76.10. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:28 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 5,300 | $2.59 | $13,727.00 |
DisclosureSEC source: 0001438133-20-000009 · wf-form4_158051331288537.xml · nonDerivative · entry 5 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,300 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:28 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,700 | $76.00 | $129,200.00 |
DisclosureSEC source: 0001438133-20-000009 · wf-form4_158051331288537.xml · nonDerivative · entry 4 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person August 22, 2019. F4 · price: The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $75.73 to $76.48. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:28 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,700 | $19.00 | $32,300.00 |
DisclosureSEC source: 0001438133-20-000009 · wf-form4_158051331288537.xml · nonDerivative · entry 3 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:28 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 1,671 | $75.56 | $126,260.76 |
DisclosureSEC source: 0001438133-20-000009 · wf-form4_158051331288537.xml · nonDerivative · entry 2 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: The shares were sold, pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person August 22, 2019. F3 · price: The price reported is the weighted average price. The shares were sold in multiple transactions at prices ranging from $75.29 to $76.29. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold. Read SEC document |
| January 29, 2020 Filed Jan 31, 2020 23:28 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | Exercise / conversionCommon Stock | 1,671 | $11.06 | $18,479.59 |
DisclosureSEC source: 0001438133-20-000009 · wf-form4_158051331288537.xml · nonDerivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,671 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents shares of common stock received upon exercise of a stock option award. Read SEC document |
| August 27, 2019 Filed Aug 29, 2019 23:30 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GiftCommon Stock | 3,000 | $69.19 | $207,570.00 |
DisclosureSEC source: 0001209191-19-047772 · doc4.xml · nonDerivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 37,000 F1 · shares: The shares were given as a bona fide gift to Orange County Community Foundation (OCCF). F2 · ownership.nature: The securities are held by the Allen Family Trust dated October 12, 1981. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 22:31 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Option · Derivative | 3,732 | $0.00 Strike: $64.66 | $0.00 |
DisclosureSEC source: 0001209191-19-038298 · doc4.xml · derivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,732 Underlying: Common Stock · 3,732 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over 12 months. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| May 02, 2019 Filed May 3, 2019 21:30 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 4,000 | $61.37 | $245,480.00 |
DisclosureSEC source: 0001209191-19-027493 · doc4.xml · nonDerivative · entry 4 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 10,000 F6 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $61.2886 and $61.385. F7 · ownership.nature: The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| May 02, 2019 Filed May 3, 2019 21:30 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 12,000 | $61.34 | $736,080.00 |
DisclosureSEC source: 0001209191-19-027493 · doc4.xml · nonDerivative · entry 3 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 40,000 F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $61.145 and $61.59. F5 · ownership.nature: The securities are held by the Allen Family Trust dated October 12, 1981. Read SEC document |
| May 02, 2019 Filed May 3, 2019 21:30 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 500 | $61.31 | $30,655.00 |
DisclosureSEC source: 0001209191-19-027493 · doc4.xml · nonDerivative · entry 2 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,500 F3 · ownership.nature: The securities are held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Jake Allen Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon. Read SEC document |
| May 02, 2019 Filed May 3, 2019 21:30 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 500 | $61.20 | $30,600.00 |
DisclosureSEC source: 0001209191-19-027493 · doc4.xml · nonDerivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,500 F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $61.1925 and $61.2009. F2 · ownership.nature: The securities are held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 20:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 300 | $63.21 | $18,963.00 |
DisclosureSEC source: 0001209191-19-018408 · doc4.xml · nonDerivative · entry 7 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 14,000 F9 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $63.20 and $63.24. F8 · ownership.nature: The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 20:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 3,803 | $62.79 | $238,790.37 |
DisclosureSEC source: 0001209191-19-018408 · doc4.xml · nonDerivative · entry 6 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 14,300 F7 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $62.1734 and $63.16. F8 · ownership.nature: The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 20:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 418 | $62.53 | $26,137.54 |
DisclosureSEC source: 0001209191-19-018408 · doc4.xml · nonDerivative · entry 5 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,000 F6 · ownership.nature: The securities are held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Jake Allen Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 20:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 418 | $62.53 | $26,137.54 |
DisclosureSEC source: 0001209191-19-018408 · doc4.xml · nonDerivative · entry 4 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,000 F5 · ownership.nature: The securities are held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 20:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 6,300 | $62.29 | $392,427.00 |
DisclosureSEC source: 0001209191-19-018408 · doc4.xml · nonDerivative · entry 3 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 0 F4 · ownership.nature: The securities are held in the Mary Allen Roth IRA. The Reporting Person is married to Mary Allen, and the Reporting Person may be deemed to have indirect beneficial ownership of such securities held in the Mary Allen Roth IRA. The Reporting Person disclaims beneficial ownership of such securities held in the Mary Allen Roth IRA. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 20:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 200 | $63.22 | $12,644.00 |
DisclosureSEC source: 0001209191-19-018408 · doc4.xml · nonDerivative · entry 2 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $63.19 and $63.245. F2 · ownership.direct: The securities are held in the Dick Allen Roth IRA. Read SEC document |
| March 08, 2019 Filed Mar 11, 2019 20:13 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 6,100 | $62.71 | $382,531.00 |
DisclosureSEC source: 0001209191-19-018408 · doc4.xml · nonDerivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200 F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $62.19 and $63.18. F2 · ownership.direct: The securities are held in the Dick Allen Roth IRA. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 23:20 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Options · Derivative | 25,000 | $0.00 Strike: $33.12 | $0.00 |
DisclosureSEC source: 0001209191-18-059301 · doc4.xml · derivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over 12 months. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 22:01 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 11,160 | $38.11 | $425,307.60 |
DisclosureSEC source: 0001209191-18-057613 · doc4.xml · nonDerivative · entry 4 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 52,000 F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $37.66 and $38.68. F6 · ownership.nature: The securities are held by the Allen Family Trust dated October 12, 1981. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 22:01 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 3,898 | $37.75 | $147,149.50 |
DisclosureSEC source: 0001209191-18-057613 · doc4.xml · nonDerivative · entry 3 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 18,103 F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $37.72 and $37.79. F4 · ownership.nature: The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein. F5 · ownership.nature: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $37.66 and $38.68. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 22:01 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 82 | $37.88 | $3,106.16 |
DisclosureSEC source: 0001209191-18-057613 · doc4.xml · nonDerivative · entry 2 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,418 F2 · ownership.nature: The securities are held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 22:01 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | SaleCommon Stock | 82 | $37.96 | $3,112.72 |
DisclosureSEC source: 0001209191-18-057613 · doc4.xml · nonDerivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,418 F1 · ownership.nature: The securities are held by the Gammon Children's 2000 Trust FBP Jake Allen Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Jake Allen Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon. Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 21:05 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | PurchaseCommon Stock | 8,103 | $3.84 | $31,115.52 |
DisclosureSEC source: 0001209191-18-017674 · doc4.xml · nonDerivative · entry 5 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 22,001 F8 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $3.83 and $3.85. F9 · ownership.nature: The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 21:05 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | PurchaseCommon Stock | 6,300 | $3.88 | $24,444.00 |
DisclosureSEC source: 0001209191-18-017674 · doc4.xml · nonDerivative · entry 4 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,300 F6 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $3.88 and $3.90. F7 · ownership.direct: The securities are held in the Dick Allen Roth IRA. Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 21:05 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | PurchaseCommon Stock | 6,300 | $3.89 | $24,507.00 |
DisclosureSEC source: 0001209191-18-017674 · doc4.xml · nonDerivative · entry 3 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 6,300 F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $3.89 and $3.90. F5 · ownership.nature: The securities are held in the Mary Allen Roth IRA. The Reporting Person is married to Mary Allen, and the Reporting Person may be deemed to have indirect beneficial ownership of such securities held in the Mary Allen Roth IRA. The Reporting Person disclaims beneficial ownership of such securities held in the Mary Allen Roth IRA. Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 21:05 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | PurchaseCommon Stock | 2,418 | $3.96 | $9,575.28 |
DisclosureSEC source: 0001209191-18-017674 · doc4.xml · nonDerivative · entry 2 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,500 F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $3.95 and $3.96. F3 · ownership.nature: The securities are held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon. The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon. Read SEC document |
| March 06, 2018 Filed Mar 7, 2018 21:05 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | PurchaseCommon Stock | 2,418 | $3.96 | $9,575.28 |
DisclosureSEC source: 0001209191-18-017674 · doc4.xml · nonDerivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 2,500 F1 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $3.95 and $3.96. F2 · ownership.nature: The securities are held by the Gammon Children's 2000 Trust FBP Jake Allen Gammon.The Reporting Person is co-trustee of the Gammon Children's 2000 Trust FBO Jake Allen Gammon and has shared voting and investment power over the securities held by the Gammon Children's 2000 Trust FBO Hannah Lee Gammon and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by the Gammon Children's 2000 Trust FBO Jake Allen Gammon. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 21:58 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | PurchaseCommon Stock | 10,000 | $2.00 | $20,000.00 |
DisclosureSEC source: 0001209191-18-009613 · doc4.xml · nonDerivative · entry 2 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 13,898 F1 · balance_after: The amount of securities beneficially owned following the reported transactions reflects the 10 for 1 reverse stock split of the Issuer's issued and outstanding common stock which was effective on October 9, 2017. F3 · ownership.nature: The securities are held by Allen Cornerstone Ventures L.P. The Reporting Person is the managing partner of Allen Cornerstone Ventures L.P. and may be deemed to have indirect beneficial ownership of such securities. The Reporting Person disclaims beneficial ownership of such securities held by Allen Cornerstone Ventures L.P., except to the extent of his proportionate pecuniary interest therein. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 21:58 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | PurchaseCommon Stock | 50,000 | $2.00 | $100,000.00 |
DisclosureSEC source: 0001209191-18-009613 · doc4.xml · nonDerivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 63,160 F1 · balance_after: The amount of securities beneficially owned following the reported transactions reflects the 10 for 1 reverse stock split of the Issuer's issued and outstanding common stock which was effective on October 9, 2017. F2 · ownership.nature: The securities are held by the Allen Family Trust dated October 12, 1981. Read SEC document |
| December 01, 2017 Filed Dec 5, 2017 23:04 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Option · Derivative | 5,300 | $0.00 Strike: $2.59 | $0.00 |
DisclosureSEC source: 0001209191-17-064037 · doc4.xml · derivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,300 Underlying: Common Stock · 5,300 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. The grant is contingent upon future stockholder approval of an increase in the number of shares reserved for issuance under the 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over twelve (12) months. F3 · derivative.expiration_date: The expiration date for these options is ten (10) years from the date of grant. Read SEC document |
| November 15, 2017 Filed Nov 17, 2017 23:25 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Options · Derivative | 1,700 | $2.54 Strike: $2.54 | $4,318.00 |
DisclosureSEC source: 0001209191-17-061605 · doc4.xml · derivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,700 Underlying: Common Stock · 1,700 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over 12 months. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 01:00 UTC | TANDEM DIABETES CARE INC TNDM · Entity 4682 | GrantStock Options · Derivative | 17,000 | $0.00 Strike: $1.90 | $0.00 |
DisclosureSEC source: 0001209191-16-150720 · doc4.xml · derivative · entry 1 Allen Dick · CIK 0001582779 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires not disclosed F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan. F2 · derivative.exercise_date: All shares subject to the option will vest in equal monthly installments over 12 months. F3 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.